The Media Line led over twenty years ago in pioneering the American independent news agency in the Middle East, arguably the first in the region. We have always stayed true to our mission: to provide you with contextual sourced and trustworthy news. In an age of fake news masquerading as journalism, The Media Line plays a crucial role in providing fact-based news that deserves your support.

We're proud of the dozens of young students we've trained in our Press and Policy Student Program who will form the vanguard of the next generation of journalists to the benefit of countless millions of news readers.

Look out for exciting new additions as we enter 2022.

We thank our loyal readers and wish you all the happiest of holidays.
The Media Line

Non-profit news needs public support.
Please support us with your generous contributions:
Tel Aviv U Researchers Identify Early Alzheimer’s Signal in Brain Activity
Tel Aviv University neuorscience researchers Professor Inna Slutsky, Daniel Zarhin and Refaela Atsmon. (Dr. Tal Laviv/TAU)

Tel Aviv U Researchers Identify Early Alzheimer’s Signal in Brain Activity

Researchers at Tel Aviv University have discovered a pathological brain activity that could enable an early diagnosis of Alzheimer’s disease.  Brains with increased activity in the hippocampus during anesthesia and sleep, resulting from failure in the mechanism that stabilizes the neural network, precedes the onset of Alzheimer’s first symptoms by many years and could enable an early diagnosis, according to the study published last month in the scientific journal Cell Reports. The study was led by Professor Inna Slutsky and doctoral students Daniel Zarhin and Refaela Atsmon from the Sackler Faculty of Medicine and the Sagol School of Neuroscience at Tel Aviv University.

The researchers used animal models for Alzheimer’s, focusing on the hippocampal region of the brain, which plays a key role in memory processes, and is known to be impaired in Alzheimer’s patients. They compared the brain activity when the animals were awake, asleep or under anesthesia.

“Innovative imaging technologies developed in recent years have revealed that amyloid deposits, a hallmark of Alzheimer’s disease pathology, are formed in patients’ brains as early as 10-20 years before the onset of typical symptoms such as memory impairment and cognitive decline. Unfortunately, most efforts to treat Alzheimer’s disease by reducing the amount of amyloid-beta proteins and their aggregation have failed. If we could detect the disease at the pre-symptomatic stage, and keep it in a dormant phase for many years, this would be a tremendous achievement in the field. We believe that identifying a signature of aberrant brain activity in the pre-symptomatic stage of Alzheimer’s and understanding the mechanisms underlying its development is a key to effective treatment,” Slutsky said in a statement.

The study suggests that an existing treatment for multiple sclerosis may help to stabilize brain activity at early disease stage by suppressing this type of anesthesia-induced aberrant brain activity. “The instability in neuronal activity which we found in this study is known from epilepsy. In a previous study we discovered that an existing drug for multiple sclerosis may help epilepsy patients by activating a homeostatic mechanism that lowers the set point of neural activity. Doctoral student Shiri Shoob examined the effect of the drug on hippocampal activity in the animal model for Alzheimer’s and found that in this case also the drug stabilizes activity and reduces pathological activity observed during anesthesia,” Slutsky said.

The researchers now plan to collaborate with medical centers in Israel and worldwide to test whether the mechanisms discovered in animal models can also be identified in patients with early-stage Alzheimer’s disease.

Did you know we’re celebrating our 20th Anniversary as the 1st American News Agency exclusively covering the Middle East?

  • The Middle East landscape is changing rapidly.
  • The roads in the region open to new possibilities.
  • The Media Line continues to pave the way to a far greater understanding of the region’s land, people, policies and governments through our trusted, fact-based news.

We’re an independent, ad-free, non-profit news agency and rely on friends like you!

Please make your gift today.
Thank you!

We paved the way to be the Trusted Mid East News you can rely on!

We’re an independent, ad-free, non-profit news agency and rely on friends like you!

Invest in the
Trusted Mideast
News source.
We are on the
front lines.

Personalize Your News
Upgrade your experience by choosing the categories that matter most to you.
Click on the icon to add the category to your Personalize news
Browse Categories and Topics
Wake up to the Trusted Mideast News source Mideast Daily News Email
By subscribing, you agree to The Media Line terms of use and privacy policy.
Wake up to the Trusted Mideast News source Mideast Daily News Email
By subscribing, you agree to The Media Line terms of use and privacy policy.